NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 328 filers reported holding NOVOCURE LTD in Q1 2021. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $245,869 | -4.7% | 3,352 | -1.2% | 0.00% | 0.0% |
Q3 2022 | $258,000 | +20.0% | 3,394 | +9.6% | 0.00% | 0.0% |
Q2 2022 | $215,000 | -14.0% | 3,096 | +2.7% | 0.00% | 0.0% |
Q1 2022 | $250,000 | -12.0% | 3,016 | -20.3% | 0.00% | 0.0% |
Q4 2021 | $284,000 | -34.4% | 3,782 | +1.4% | 0.00% | 0.0% |
Q3 2021 | $433,000 | -43.9% | 3,729 | +7.2% | 0.00% | -50.0% |
Q2 2021 | $772,000 | +259.1% | 3,479 | +114.1% | 0.00% | +100.0% |
Q1 2021 | $215,000 | -68.7% | 1,625 | -59.1% | 0.00% | -50.0% |
Q4 2020 | $687,000 | +175.9% | 3,972 | +7.3% | 0.00% | +100.0% |
Q1 2020 | $249,000 | -40.3% | 3,702 | -25.2% | 0.00% | -50.0% |
Q4 2019 | $417,000 | +19.8% | 4,952 | +6.4% | 0.00% | 0.0% |
Q3 2019 | $348,000 | -57.0% | 4,652 | -72.3% | 0.00% | -50.0% |
Q1 2019 | $809,000 | -49.7% | 16,800 | -45.3% | 0.00% | -50.0% |
Q3 2018 | $1,609,000 | – | 30,700 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
StepStone Group LP | 1,365,479 | $29,767,000 | 21.90% |
Tamarack Advisers, LP | 1,115,000 | $24,307,000 | 11.56% |
COURAGE CAPITAL MANAGEMENT LLC | 275,000 | $5,995,000 | 4.57% |
GREAT POINT PARTNERS LLC | 753,481 | $16,426,000,000 | 2.44% |
HARTLINE INVESTMENT CORP/ | 404,052 | $8,808,000 | 2.42% |
Pier Capital, LLC | 346,350 | $7,550,000 | 1.29% |
Rhenman & Partners Asset Management AB | 435,000 | $9,483,000 | 1.17% |
HIGHLINE CAPITAL MANAGEMENT, L.P. | 1,029,910 | $22,452,000 | 0.77% |
PEREGRINE CAPITAL MANAGEMENT LLC | 922,468 | $20,110,000 | 0.49% |
Hodges Capital Management Inc. | 285,500 | $6,224,000 | 0.49% |